These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35880758)

  • 1. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
    Mitchell JM; Gresenz CR
    Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Documenting Horizontal Integration Among Urologists Who Treat Prostate Cancer.
    Mitchell JM; Gresenz CR
    Med Care Res Rev; 2022 Feb; 79(1):141-150. PubMed ID: 33331217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urologist Practice Structure and Spending for Prostate Cancer Care.
    Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB
    Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
    Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK
    Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
    Mitchell JM
    N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
    Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
    Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
    Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline MK; Caram MEV; Shahinian VB; Hollenbeck BK
    Cancer; 2024 May; 130(9):1609-1617. PubMed ID: 38146764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.
    Ramsey SD; Zeliadt SB; Fedorenko CR; Blough DK; Moinpour CM; Hall IJ; Smith JL; Ekwueme DU; Fairweather ME; Thompson IM; Keane TE; Penson DF
    World J Urol; 2011 Feb; 29(1):3-9. PubMed ID: 20959991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection.
    Mitchell JM
    Health Aff (Millwood); 2012 Apr; 31(4):741-9. PubMed ID: 22492891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
    JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care delivery system contributions to management of newly diagnosed prostate cancer.
    Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
    Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Active Surveillance for Prostate Cancer.
    Lai LY; Shahinian VB; Oerline MK; Kaufman SR; Skolarus TA; Caram MEV; Hollenbeck BK
    JCO Oncol Pract; 2021 Nov; 17(11):e1678-e1687. PubMed ID: 33830822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia.
    Strope SA; Elliott SP; Smith A; Wei JT; Wilt TJ; Saigal CS;
    Urology; 2011 Mar; 77(3):535-40. PubMed ID: 21256570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer.
    Lai LY; Kaufman SR; Oerline MK; Caram MEV; Maganty A; Hollenbeck BK; Shahinian VB
    JNCI Cancer Spectr; 2022 Mar; 6(2):. PubMed ID: 35603854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice-Level Adoption of Conservative Management for Prostate Cancer.
    Modi PK; Kaufman SR; Herrel LA; Dupree JM; Luckenbaugh AN; Skolarus TA; Hollenbeck BK; Shahinian VB
    J Oncol Pract; 2019 Oct; 15(10):e863-e869. PubMed ID: 31509481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
    BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.